Michael B Hoffman

CIK 1290208 · Chairman and CEO · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.26M

Companies

5

Total Filings

41

Lifetime Open-Market Net

$21.63M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TDACW Chairman and CEO $1.42 $0 1 2026-05-29
ANVS Director 3,514,458 $1.78 $6.26M $4.46M 21 2026-05-21
Traws Pharma, Inc. (ONTXW) Delisted Director 564 $0.07 $38 -$95.3K 7 2020-08-31
Traws Pharma, Inc. (ONTX.W) Delisted Director 982,549 $0 1 2016-08-10
Traws Pharma, Inc. (ONTX) Delisted Director 4,537,029 $1.00 $4.52M $17.27M 11 2016-05-20

Recent Filings · Page 2 of 5

41 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-08-20 ANVS Grant (A) +18,645 $48.3K EDGAR
2025-06-16 ANVS Grant (A) +25,001 $70.0K EDGAR
2025-06-02 ANVS Grant (A) +5,000 $12.2K EDGAR
2024-07-03 ANVS Grant (A) $0 EDGAR
2023-11-22 ANVS Grant (A) +163,880 $999.7K EDGAR
2023-11-21 ANVS Grant (A) +164,745 $1.00M EDGAR
2023-04-11 ANVS Grant (A) +59,477 $750.0K EDGAR
2023-01-20 ANVS Grant (A) $0 EDGAR
2022-01-05 ANVS Mixed +30,394 $10 EDGAR
2021-07-09 ANVS Grant (A) $0 EDGAR
Showing 1120 of 41
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.